MedTrace Logo

Randomized Clinical Trial of Rehabilitation for Subacromial Impingement Syndrome

NCT00633451 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2013-03-28

No results posted yet for this study

Summary

The purpose of this randomized double-blind clinical trial is to determine the effectiveness of manual therapy for patients with subacromial impingement syndrome of the shoulder. We hypothesize that a combination of therapeutic exercise and manual therapy to the shoulder and spine will be more effective in reducing pain and shoulder disability at short-term (6 wk) and long-term (3, 6, 12 months) as compared to therapeutic exercise only.

Conditions

  • Shoulder Impingement Syndrome

Interventions

OTHER

Manual Therapy and Exercise

Manual therapy to the thoracic spine and shoulder, and therapeutic exercise to the shoulder and spine applied in a prescribed progression of therapeutic exercise aimed at improving shoulder function.

OTHER

Exercise Only

A prescribed progression of therapeutic exercise for the shoulder and spine aimed at improving shoulder function

Sponsors & Collaborators

  • Virginia Commonwealth University

    collaborator OTHER

  • Arcadia University

    collaborator OTHER

  • National Athletic Trainers' Association Research & Education Foundation (NATA Foundation)

    collaborator OTHER

  • Proaxis Therapy

    lead INDUSTRY

Principal Investigators

  • Charles A Thigpen, PhD, PT, ATC · University of North Florida

  • Lori A Michener, PhD, PT, ATC · Virginia Commonwealth University

  • Phil McClure, PhD, PT · Arcadia University

  • Angela R Tate, PhD, PT · Arcadia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00633451 on ClinicalTrials.gov